120 related articles for article (PubMed ID: 15112962)
1. Exploitation of heparanase inhibitors from microbial metabolites using an efficient visual screening system.
Ishida K; Teruya T; Simizu S; Osada H
J Antibiot (Tokyo); 2004 Feb; 57(2):136-42. PubMed ID: 15112962
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of a selective heparanase inhibitor as an antimetastatic agent.
Ishida K; Hirai G; Murakami K; Teruya T; Simizu S; Sodeoka M; Osada H
Mol Cancer Ther; 2004 Sep; 3(9):1069-77. PubMed ID: 15367701
[TBL] [Abstract][Full Text] [Related]
3. Cloning, expression, and purification of mouse heparanase.
Miao HQ; Navarro E; Patel S; Sargent D; Koo H; Wan H; Plata A; Zhou Q; Ludwig D; Bohlen P; Kussie P
Protein Expr Purif; 2002 Dec; 26(3):425-31. PubMed ID: 12460766
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Heparanase Expression Results in Suppression of Invasion, Migration and Adhesion Abilities of Bladder Cancer Cells.
Tatsumi Y; Miyake M; Shimada K; Fujii T; Hori S; Morizawa Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471161
[TBL] [Abstract][Full Text] [Related]
5. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.
Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS
BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266
[TBL] [Abstract][Full Text] [Related]
6. Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme.
Tayel A; Abd El Galil KH; Ebrahim MA; Ibrahim AS; El-Gayar AM; Al-Gayyar MM
Eur J Pharmacol; 2014 Apr; 728():151-60. PubMed ID: 24530413
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of heparanase inhibitors in cancer therapy.
Heyman B; Yang Y
Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
[TBL] [Abstract][Full Text] [Related]
8. Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma.
Zhang Y; Li L; Wang Y; Zhang J; Wei G; Sun Y; Shen F
Biochem Biophys Res Commun; 2007 Jun; 358(1):124-9. PubMed ID: 17467664
[TBL] [Abstract][Full Text] [Related]
9. Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway.
Yu S; Lv H; Zhang H; Jiang Y; Hong Y; Xia R; Zhang Q; Ju W; Jiang L; Ou G; Zhang J; Wang S; Zhang J
Biochem Biophys Res Commun; 2017 Apr; 485(2):432-439. PubMed ID: 28209511
[TBL] [Abstract][Full Text] [Related]
10. Syntheses of novel azasugar-containing mimics of heparan sulfate fragments as potential heparanase inhibitors.
Allen KA; Brown RL; Norris G; Tyler PC; Watt DK; Zubkova OV
Carbohydr Res; 2010 Sep; 345(13):1831-41. PubMed ID: 20630499
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and evaluation of heparan sulfate mimicking glycopolymers for inhibiting heparanase activity.
Loka RS; Yu F; Sletten ET; Nguyen HM
Chem Commun (Camb); 2017 Aug; 53(65):9163-9166. PubMed ID: 28766595
[TBL] [Abstract][Full Text] [Related]
12. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the discovery of heparanase inhibitors as anti-cancer agents.
Jia L; Ma S
Eur J Med Chem; 2016 Oct; 121():209-220. PubMed ID: 27240275
[TBL] [Abstract][Full Text] [Related]
14. Dendrimer Heparan Sulfate Glycomimetics: Potent Heparanase Inhibitors for Anticancer Therapy.
Zubkova OV; Ahmed YA; Guimond SE; Noble SL; Miller JH; Alfred Smith RA; Nurcombe V; Tyler PC; Weissmann M; Vlodavsky I; Turnbull JE
ACS Chem Biol; 2018 Dec; 13(12):3236-3242. PubMed ID: 30480427
[TBL] [Abstract][Full Text] [Related]
15. Bacterial expression and functional reconstitution of human heparanase.
Winkler S; Schweiger D; Wei Z; Rajkovic E; Kungl AJ
Carbohydr Res; 2014 May; 389():72-7. PubMed ID: 24656445
[TBL] [Abstract][Full Text] [Related]
16. Screening and identification of novel B cell epitopes in human heparanase and their anti-invasion property for hepatocellular carcinoma.
Yang JM; Wang HJ; Du L; Han XM; Ye ZY; Fang Y; Tao HQ; Zhao ZS; Zhou YL
Cancer Immunol Immunother; 2009 Sep; 58(9):1387-96. PubMed ID: 19169879
[TBL] [Abstract][Full Text] [Related]
17. Heterodimer formation is essential for heparanase enzymatic activity.
Levy-Adam F; Miao HQ; Heinrikson RL; Vlodavsky I; Ilan N
Biochem Biophys Res Commun; 2003 Sep; 308(4):885-91. PubMed ID: 12927802
[TBL] [Abstract][Full Text] [Related]
18. Human platelet heparanase: purification, characterization and catalytic activity.
Freeman C; Parish CR
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1341-50. PubMed ID: 9494105
[TBL] [Abstract][Full Text] [Related]
19. New classes of potent heparanase inhibitors from ligand-based virtual screening.
Pala D; Scalvini L; Elisi GM; Lodola A; Mor M; Spadoni G; Ferrara FF; Pavoni E; Roscilli G; Milazzo FM; Battistuzzi G; Rivara S; Giannini G
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1685-1696. PubMed ID: 32907434
[TBL] [Abstract][Full Text] [Related]
20. Involvement of disulfide bond formation in the activation of heparanase.
Simizu S; Suzuki T; Muroi M; Lai NS; Takagi S; Dohmae N; Osada H
Cancer Res; 2007 Aug; 67(16):7841-9. PubMed ID: 17699790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
